AstraZeneca's Enhertu shows significant success in late-stage trials as a first-line treatment for HER2-positive metastatic ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

The approval of a new breast cancer treatment has given hope to thousands of women with an incurable form of the disease.

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

Adrenal carcinoma is a rare cancer that occurs in the adrenal glands. It’s typically treated surgically, sometimes alongside ...

More than 1800 women told us their stories of medical misogyny. Today we begin sharing those stories and building the case ...

The biotechnology company said its Bria-IMT plus check point inhibitors showed a 17.3-month survival rate for patients with hormone receptor-positive breast cancer, exceeding the 14.4 months of ...

Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ ...

I’m a 28-year-old woman recently diagnosed with breast cancer. My care team recommends starting treatment as soon as possible ...

Hormone receptor (HR)-positive HER2-negative advanced breast cancer is incurable and the aim of treatment is to delay it getting worse and extend how long people live. If the cancer has alterations in ...

The TV icon, 67, best known for her self-titled talk show Trisha, confirmed the return of her secondary breast cancer, which ...